Dalton offers fully integrated GMP Class 100 Aseptic Filling for preclinical and early stage clinical trials: sterile filling and capping of liquid-in-vial injectable drugs; aseptic filling and stoppering of liquid prefilled syringes; and aseptic filling and capping of powders.
Sterile Liquid Injectables: Aseptic fill on a state-of-the-art fill / finish crimp-cap line, capable of aseptic filling 1 – 125 ml vials with extremely low dead volume. We have validated methods in place for Sterile Filling 3, 5, and 20 ml vials up to 20,000 units per run and are currently in the process of validating a method for 2 ml vials.
Aseptic Powder Fill: Our Accofil LM14 semi-automated powder filling machines are used for aseptic filling of oligos, peptides and small molecules. We currently have a validated process to fill 1800 units in 20mL vials.
Aseptic Syringe Fill: we have capability for filling 2, 3, 5, 10 and 20 ml syringes, and a validated method for filling 2ml syringes up to 20,000 / batch.
The production of sterile prefilled syringes is on a Cozzoli F329HE-10-SS aseptic filling machine that can handle various aqueous solutions and creams with 10x10, 8x8, 6x7 and 5x6 syringe formats at a production of 5,000 - 7500 units / hour.
We are committed to serving our customers. We welcome small scale fills that may not meet the minimum number of vials required by other sterile fill companies.
Supporting our process equipment are validated services including a USP water system, pure steam generator, autoclave and depyrogenation oven. Validation capabilities include, but are not limited to, media aseptic fill simulation studies, terminal sterilization loads, autoclave equipment loads, depyrogenation oven loads, container closure integrity and process validation. Dalton also has the ability to develop or transfer technology related to aseptic processing. In addition, Dalton’s analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients. QC/QA, Microbiology and Regulatory Affairs Departments support all analytical data.
Dalton is in the planning stages of expanding its capabilities in the aseptic fill / finish and has purchased a new aspetic filling line that will allow us to fill up to 100,000 units per batch. In addition, we are expanding our lyophylization capabilities and anticipate that we will also offer this service to our clients in the near future.
We are currently manufacturing sterile medical devices and commercial products under GMP. We have manufactured many products for clinical trials (Phase I, II and III).
In a regulated industry, special care must be taken to ensure all equipment and processes are performing to specifications. Deviations can have unpredictable and sometimes devastating results. Therefore, we pay special attention to equipment qualification and process validation to provide full regulatory compliance for its clients. We follow the strictest guidelines, perform the most rigorous testing and execute studies in a timely fashion to ensure your product is of the highest quality when it reaches its destination.
Dalton has capabilities to develop, create and execute validation protocols and studies required for your products and equipment in accordance with current Guidelines (HPFBI, FDA, EP, ICH, WHO) and acceptable formats (prospective, retrospective and concurrent). These include process validation, cleaning validation, aseptic processing, terminal sterilization, environmental control, IQ/OQ/PQ/PV and utility qualifications. Statistical analysis and decision making is also part of our service.
We stand by our products, which are manufactured to the highest quality standards. Learn more about our Custom Drug Synthesis products.
If what you are looking for is not on the list please contact us at 1-800-567-5060 or 416-661-2102 or email us and we will gladly meet your GMP aseptic filling needs.